Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pinilla

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Anales De Medicina Interna (Madrid, Spain : 1984)|July 1, 1993
[Erythroderma caused by carbamazepine. Diagnosis with skin patch]A Blasco Sarramían, J Pinilla Moraza, M B Atares Pueyo, et al.
Vox Sanguinis|August 6, 1998
Human parvovirus B19 antibodies are less frequent among patients treated with factor IX concentrate inactivated by ultrafiltration: a report from a single Spanish institutionM A Canales, J Pinilla, P Mateos, et al.
Medicina Clinica|January 28, 1995
[Tuberculosis in La Rioja from 1988 to 1993. Clinical course, localization, influence of human immunodeficiency virus infection, and sensitivity of mycobacterial tests]P Labarga Echeverría, M Perucha González, E Jiménez Gómez, et al.
American Journal of Physiology. Cell Physiology|June 10, 2011
Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound ironJorge J Pinilla-Tenas, Brian K Sparkman, Ali Shawki, et al.
Hepato-Gastroenterology|December 5, 1998
Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factorsM A Del Pozo, J R Arias, J Pinilla, et al.
Leukemia|July 6, 2012
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II studyF J Giles, P D le Coutre, J Pinilla-Ibarz, et al.
Leukemia|March 20, 2009
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapyS Mustjoki, M Ekblom, T P Arstila, et al.
Leukemia|November 24, 2012
Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intoleranceE Jabbour, P D le Coutre, J Cortes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2007
Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in SpainM Diez, A Diaz, M J Bleda, et al.
Molecular Oncology|May 11, 2015
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferationK V Woan, M Lienlaf, P Perez-Villaroel, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Anales De Medicina Interna (Madrid, Spain : 1984)|July 1, 1993
[Erythroderma caused by carbamazepine. Diagnosis with skin patch]A Blasco Sarramían, J Pinilla Moraza, M B Atares Pueyo, et al.
Vox Sanguinis|August 6, 1998
Human parvovirus B19 antibodies are less frequent among patients treated with factor IX concentrate inactivated by ultrafiltration: a report from a single Spanish institutionM A Canales, J Pinilla, P Mateos, et al.
Medicina Clinica|January 28, 1995
[Tuberculosis in La Rioja from 1988 to 1993. Clinical course, localization, influence of human immunodeficiency virus infection, and sensitivity of mycobacterial tests]P Labarga Echeverría, M Perucha González, E Jiménez Gómez, et al.
American Journal of Physiology. Cell Physiology|June 10, 2011
Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound ironJorge J Pinilla-Tenas, Brian K Sparkman, Ali Shawki, et al.
Hepato-Gastroenterology|December 5, 1998
Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factorsM A Del Pozo, J R Arias, J Pinilla, et al.
Leukemia|July 6, 2012
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II studyF J Giles, P D le Coutre, J Pinilla-Ibarz, et al.
Leukemia|March 20, 2009
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapyS Mustjoki, M Ekblom, T P Arstila, et al.
Leukemia|November 24, 2012
Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intoleranceE Jabbour, P D le Coutre, J Cortes, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2007
Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in SpainM Diez, A Diaz, M J Bleda, et al.
Molecular Oncology|May 11, 2015
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferationK V Woan, M Lienlaf, P Perez-Villaroel, et al.
Pageof 10